Results 11 to 20 of about 21,132 (237)

BENEFITS OF PROKINETICS, GASTROPARESIS DIET, OR NEUROMODULATORS ALONE OR IN COMBINATION FOR SYMPTOMS OF GASTROPARESIS.

Clinical Gastroenterology and Hepatology, 2023
BACKGROUND AND AIMS Prokinetics have limited effectiveness for treating symptoms of gastroparesis. Thus, alternative or adjunct therapies like gastroparesis diets or neuromodulators are often prescribed. Their therapeutic benefits alone or in combination
W. Hasler, Allen A. Lee, B. Moshiree, B. Surjanhata, S. Rao, H. Parkman, Linda A Nguyen, I. Sarosiek, John M Wo, Michael I. Schulman, Richard W McCallum, Braden Kuo   +11 more
semanticscholar   +3 more sources

Diabetic Gastroparesis [PDF]

Endocrine Reviews, 2019
AbstractThis review covers the epidemiology, pathophysiology, clinical features, diagnosis, and management of diabetic gastroparesis, and more broadly diabetic gastroenteropathy, which encompasses all the gastrointestinal manifestations of diabetes mellitus.
Adil E Bharucha, Yogish C Kudva, David O Prichard   +2 more
openaire   +3 more sources

Management of diabetic gastroparesis

The Saudi Journal of Gastroenterology, 2011
Symptoms suggestive of gastroparesis occur in 5% to 12% of patients with diabetes. Such a complication can affect both prognosis and management of the diabetes; therefore, practicing clinicians are challenged by the complex management of such cases ...
Badr M Aljarallah
doaj   +2 more sources

Status of Brain Imaging in Gastroparesis

Gastrointestinal Disorders, 2020
The pathophysiology of nausea and vomiting in gastroparesis is complicated and multifaceted involving the collaboration of both the peripheral and central nervous systems.
Zorisadday Gonzalez, Richard W. McCallum
doaj   +2 more sources

Gastroparesis: Prevalence, Clinical Significance and Treatment [PDF]

Canadian Journal of Gastroenterology, 2001
The application of novel techniques to quantify gastric motor function and gastric emptying has yielded important insights into the prevalence, pathogenesis and clinical sequelae of gastroparesis.
Michael Horowitz, Yu-Chung Su, Christopher K Rayner, Karen L Jones   +3 more
doaj   +2 more sources

ACG Clinical Guideline: Gastroparesis

American Journal of Gastroenterology, 2022
Gastroparesis is characterized by symptoms suggesting retention of food in the stomach with objective evidence of delayed gastric emptying in the absence of mechanical obstruction in the gastric outflow.
M. Camilleri, B. Kuo, L. Nguyen, V. Vaughn, Jessica Petrey, K. Greer, Rena H. Yadlapati, T. Abell   +7 more
semanticscholar   +1 more source

Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial

Gut, 2022
Objective Endoscopic pyloromyotomy (G-POEM) is a minimally invasive treatment option with promising uncontrolled outcome results in patients with gastroparesis.
J. Martínek, R. Hustak, Jan Mareš, Z. Vackova, J. Spicak, E. Kieslichová, M. Buncová, D. Pohl, S. Amin, J. Tack   +9 more
semanticscholar   +1 more source

Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathological features

Gastroenterology, 2021
Background. The aim of this study was to clarify the pathophysiology of functional dyspepsia (FD), a highly prevalent gastrointestinal syndrome, and its relationship with the better understood syndrome of gastroparesis. Methods.
P. Pasricha, M. Grover, Katherine P. Yates, Thomas L. Abell, Cheryl E. Bernard, Kenneth L. Koch, R. McCallum, I. Sarosiek, B. Kuo, Robert S. Bulat, Jiande D. Z. Chen, Robert J. Shulman, Linda A. Lee, J. Tonascia, L. Miriel, F. Hamilton, G. Farrugia, H. Parkman, P. Pasricha, Robert Burns, G. Hernandez, M. McKnight, April Mendez, K. Staller, Andrea H. Thurler, Christopher Vélez, Casey J Silvernale, Z. Malik, A. Maurer, Amiya Palit, N. Vega, Denise Vasquez, S. Connery, Karina Espino, M. Friedman, Thomas L. Abell, A. Stocker, Bridget A. Cannon, L. McElmurray, K. Cooper, C. McBride, Kenneth L. Koch, Lynn Baxter, Anya L. Brown, Paula S. Stuart, Amirah Abdullah, William I. Snape, Nata DeVole, K. Earle, K. Kirkeby, Candi Lee, Mimi S. Lin, D. Troyer, Anna von Bakonyi, Robert J. Shulman, B. Chumpitazi, Liz Febo-Rodriguez, J. Hollier, C. Bouette, Heather Charron, S. Nurko, S. Wall, Madeline Kane, K. Williams, Lina Yossef-Salameh, F. Woodley, Cheryl E. Bernard, Jose Serrano, S. Hall, S. James, R. Torrance, M. Adamo, Patricia H. Belt, J. Dodge, M. Donithan, M. Isaacson, Jill Meinert, L. Miriel, Emily P. Sharkey, Jacqueline Smith, Michael S. Smith, Alice Sternberg, M. V. Van Natta, A. Wagoner, L. Wilson, Goro Yamada, Katherine P. Yates   +86 more
semanticscholar   +1 more source

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology journal, 2021
Background Gastroparesis is a condition characterized by epigastric symptoms and delayed gastric emptying (GE) rate in the absence of any mechanical obstruction.
J. Schol, L. Wauters, R. Dickman, V. Drug, A. Mulak, J. Serra, P. Enck, J. Tack   +7 more
semanticscholar   +1 more source

Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis

Drugs in R&D, 2023
Background Dopamine antagonists are the main pharmacological options to treat gastroparesis. The aim of this study was to conduct a systematic literature review (SLR) to evaluate the profile of adverse events (AEs) of dopamine antagonists used in the ...
D. Junqueira, D. Bennett, Susanna Y. Huh, K. Fahrbach, Binod Neupane, M. Betts   +5 more
semanticscholar   +1 more source